This inventor holds 1 USPTO granted patent. Top assignees: Ajinomoto Co., Ltd., Morishita Pharmaceuticals Co. Ltd.. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1980
Title: Takashi Yoshihama: Innovator in Glucan Solutions
Introduction
Takashi Yoshihama is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of stable aqueous solutions of glucans and glucan derivatives. His work has implications for medical research, especially in cancer treatment.
Latest Patents
Yoshihama holds a patent for "Stable aqueous solutions of glucans and glucan derivatives capable of inhibiting the growth of sarcoma 180 in mice." This invention addresses the challenge of solubility and stability in aqueous solutions of glucans, which are known to be only sparingly soluble in water. His innovative approach involves the use of water-soluble dextran, hydroxyethyl starch, carboxymethyl cellulose, or polyethylene glycol to create relatively concentrated and stable solutions, particularly when combined with hexoses, pentoses, or sugar alcohols containing 5 or 6 carbon atoms. This patent highlights his expertise in formulating effective solutions for therapeutic applications.
Career Highlights
Throughout his career, Yoshihama has worked with prominent companies such as Ajinomoto Co., Ltd. and Morishita Pharmaceuticals Co. Ltd. His experience in these organizations has allowed him to apply his research in practical settings, contributing to advancements in pharmaceutical formulations.
Collaborations
Yoshihama has collaborated with esteemed colleagues, including Mitsuharu Fujii and Tatsuo Kuoka. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Takashi Yoshihama's contributions to the field of glucan solutions demonstrate his commitment to advancing medical research and therapeutic applications. His innovative patent and collaborations with industry leaders underscore his role as a significant inventor in biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile